Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity

被引：0
|
作者：
Wang, Sangsang [1 ]
Yu, Diao [2 ,4 ]
Zhang, Junwu [3 ,5 ]
机构：
[1] Ningbo Ninth Hosp, Dept Lab Med, Ningbo, Peoples R China
[2] Bijie Hosp, Dept Clin Lab, Zhejiang Prov Peoples Hosp, Bijie, Guizhou, Peoples R China
[3] Zhejiang Chinese Med Univ, Dept Clin Lab, Wenzhou TCM Hosp, Wenzhou, Peoples R China
[4] Bijie Hosp, Dept Nephrol, Zhejiang Prov Peoples Hosp, Bijie 551700, Peoples R China
[5] Zhejiang Chinese Med Univ, Wenzhou TCM Hosp, Dept Clin Lab, 9 Jiaowei Rd, Wenzhou 325000, Peoples R China
来源：
BLOOD CELLS MOLECULES AND DISEASES | 2024年 / 105卷
关键词：
gamma ' fibrinogen levels; Biomarker; COVID-19 respiratory disease severity;
D O I：
10.1016/j.bcmd.2024.102826
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Regarding γ′ fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, C. N.
    Olynyk, John K.
    Farrell, David H.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2024, 105
  • [2] ?' fibrinogen levels as a biomarker of COVID-19 respiratory disease severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, C. N.
    Olynyk, John K.
    Farrell, David H.
    [J]. BLOOD CELLS MOLECULES AND DISEASES, 2023, 101
  • [3] Gamma' Fibrinogen Levels As a Biomarker of COVID-19 Severity
    Kornblith, Lucy Z.
    Sadhanandhan, Bindhya
    Arun, Sreepriya
    Long, Rebecca
    Johnson, Alicia J.
    Noll, Jamie
    Ramchand, Cn
    Olynyk, John K.
    Farrell, David H.
    [J]. BLOOD, 2022, 140 : 2749 - 2750
  • [4] Serum calprotectin as a novel biomarker for severity of COVID-19 disease
    Kaya, Tezcan
    Yaylaci, Selcuk
    Nalbant, Ahmet
    Yildirim, Ilhan
    Kocayigit, Havva
    Cokluk, Erdem
    Sekeroglu, Mehmet Ramazan
    Koroglu, Mehmet
    Guclu, Ertugrul
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (01) : 59 - 64
  • [5] Serum calprotectin as a novel biomarker for severity of COVID-19 disease
    Tezcan Kaya
    Selçuk Yaylacı
    Ahmet Nalbant
    İlhan Yıldırım
    Havva Kocayiğit
    Erdem Çokluk
    Mehmet Ramazan Şekeroğlu
    Mehmet Köroğlu
    Ertuğrul Güçlü
    [J]. Irish Journal of Medical Science (1971 -), 2022, 191 : 59 - 64
  • [6] Proteinuria as a Biomarker for COVID-19 Severity
    Ouahmi, Hajar
    Courjon, Johan
    Morand, Lucas
    Francois, Juliette
    Bruckert, Vincent
    Lombardi, Romain
    Esnault, Vincent
    Seitz-Polski, Barbara
    Demonchy, Elisa
    Dellamonica, Jean
    Boyer-Suavet, Sonia
    [J]. FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [7] Soluble Siglec-9 as a Biomarker for COVID-19 Disease Severity
    Fazal, Abid
    Shahul, Sajid
    Dreixler, John
    [J]. ANESTHESIA AND ANALGESIA, 2022, 134 : 287 - 288
  • [8] Serum biomarker panel for disease severity and prognosis in patients with COVID-19
    Li, Jing
    Tang, Mingyang
    Liu, Didi
    Xie, Zongyu
    Wang, Fengchao
    Yang, Yanqing
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (02)
  • [9] Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients
    Welder, Daniel
    Jeon-Slaughter, Haekyung
    Ashraf, Bilal
    Choi, Sung-Hee
    Chen, Weina
    Ibrahim, Ibrahim
    Bat, Taha
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (03) : 530 - 536
  • [10] D-Dimer as a potential biomarker for disease severity in COVID-19
    Ozen, Mert
    Yilmaz, Atakan
    Cakmak, Vefa
    Beyoglu, Resad
    Oskay, Alten
    Seyit, Murat
    Senol, Hande
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2021, 40 : 55 - 59
12345